Identification of Androgen Receptor Modulators in a Prostate Cancer Cell Line Microarray Compendium
暂无分享,去创建一个
Nicole Kleinstreuer | John P Rooney | J Christopher Corton | J. Corton | B. Chorley | J. Rooney | N. Kleinstreuer | Brian Chorley
[1] V. Noé,et al. Urolithin A causes p21 up-regulation in prostate cancer cells , 2016, European Journal of Nutrition.
[2] Joanne M Yeakley,et al. A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling , 2017, PloS one.
[3] I. Mills,et al. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis , 2011, The EMBO journal.
[4] K. Lam,et al. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer , 2016, Nature Medicine.
[5] Parantu K. Shah,et al. Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer , 2014, Science Signaling.
[6] Scott Auerbach,et al. Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium , 2015, Nuclear receptor signaling.
[7] Shu-Dong Zhang,et al. Application of connectivity mapping in predictive toxicology based on gene-expression similarity. , 2010, Toxicology.
[8] R. Judson,et al. Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform. , 2017, Toxicology.
[9] D. Kazmin,et al. Pharmacological uncoupling of androgen receptor-mediated prostate cancer cell proliferation and prostate-specific antigen secretion. , 2003, Cancer research.
[10] F. Claessens,et al. Comparing the rules of engagement of androgen and glucocorticoid receptors , 2017, Cellular and Molecular Life Sciences.
[11] David M. Reif,et al. Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. , 2014, Current opinion in pharmacology.
[12] T. Golub,et al. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. , 2006, Cancer cell.
[13] Karl G. Kohlgraf,et al. Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor–Positive Prostate Cancer Cells , 2006, Molecular Cancer Research.
[14] Richard A Becker,et al. Developing scientific confidence in HTS-derived prediction models: lessons learned from an endocrine case study. , 2014, Regulatory toxicology and pharmacology : RTP.
[15] Robert J Kavlock,et al. Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms , 2014, Nature Biotechnology.
[16] K. A. Klein,et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice , 1997, Nature Medicine.
[17] David M. Reif,et al. Analysis of the Effects of Cell Stress and Cytotoxicity onIn Vitro Assay Activity Across a Diverse Chemical and Assay Space , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Ruili Huang,et al. Predictive endocrine testing in the 21st century using in vitro assays of estrogen receptor signaling responses. , 2014, Environmental science & technology.
[19] Jianfei Qi,et al. Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines , 2016, Scientific Reports.
[20] N. Guseva,et al. Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor , 2012, Oncotarget.
[21] J. Palvimo,et al. Androgen receptor amplification is reflected in the transcriptional responses of Vertebral-Cancer of the Prostate cells , 2011, Molecular and Cellular Endocrinology.
[22] Nisha S. Sipes,et al. In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme. , 2014, Basic & clinical pharmacology & toxicology.
[23] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[24] R. Vessella,et al. Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. , 2009, Cancer research.
[25] Zhou Zhu,et al. Dose-dependent effects of small-molecule antagonists on the genomic landscape of androgen receptor binding , 2012, BMC Genomics.
[26] L. Borsu,et al. Histone deacetylases are required for androgen receptor function in hormone-sensitive and castrate-resistant prostate cancer. , 2009, Cancer research.
[27] V. Arora,et al. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer , 2015, Nature Reviews Cancer.
[28] Ruili Huang,et al. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[29] L. Giudice,et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.
[30] Joshua M. Korn,et al. An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). , 2013, Cancer discovery.
[31] Ruili Huang,et al. Development and Validation of a Computational Model for Androgen Receptor Activity , 2016, Chemical research in toxicology.
[32] J. Isaacs,et al. The Prostate 69 : 1724 ^ 1729 ( 2009 ) TissueCultureMedia SupplementedWith 10 % Fetal Calf SerumContains aCastrate Levelof Testosterone , 2009 .
[33] Hideo Araki,et al. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. , 2003, Cancer research.
[34] J. Céraline,et al. Constitutively Active Androgen Receptor Variants Upregulate Expression of Mesenchymal Markers in Prostate Cancer Cells , 2013, PloS one.
[35] J. Corton,et al. Identification of Modulators of the Nuclear Receptor Peroxisome Proliferator-Activated Receptor α (PPARα) in a Mouse Liver Gene Expression Compendium , 2015, PloS one.
[36] Lauren M Aleksunes,et al. Screening a mouse liver gene expression compendium identifies modulators of the aryl hydrocarbon receptor (AhR). , 2015, Toxicology.
[37] Yu-Mei Tan,et al. Adverse Outcome Pathways—Organizing Toxicological Information to Improve Decision Making , 2016, The Journal of Pharmacology and Experimental Therapeutics.
[38] G. Jenster,et al. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens , 1992, Journal of Steroid Biochemistry and Molecular Biology.
[39] Edwin Cheung,et al. A transcriptional repressor co‐regulatory network governing androgen response in prostate cancers , 2012, The EMBO journal.
[40] P. Dervan,et al. Suppression of androgen receptor-mediated gene expression by a sequence-specific DNA-binding polyamide , 2007, Proceedings of the National Academy of Sciences.
[41] L. Butler,et al. Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms. , 2015, Endocrine-related cancer.
[42] Raymond R Tice,et al. Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Hongjuan Cui,et al. Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements. , 2011, Molecular endocrinology.
[44] Daehee Hwang,et al. Integrated Expression Profiling and ChIP-seq Analyses of the Growth Inhibition Response Program of the Androgen Receptor , 2009, PloS one.
[45] M. Ronaghi,et al. Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data , 2010, PloS one.
[46] M. Waters,et al. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods. , 2010, Mutation research.
[47] Erick R. Scott,et al. Sensitive, multiplex and direct quantification of RNA sequences using a modified RASL assay , 2014, Nucleic acids research.